Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00315146 · ClinicalTrials.gov registry record · Phase 4

Optimizing Body Composition for Function in Older Adults

A Phase 4 study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
Phase 4
Development phase
88
Enrollment target

NCT00315146 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 88 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00315146, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
Phase 4
Development phase
88 participants
Enrollment target

Study Summary

The purpose of this pilot study is to compare two strategies intended to improve the health of overweight older adults by improving body composition. One strategy, resistance training, is designed to preserve skeletal muscle mass. The other strategy, the use of a PPAR-γ agonist, is designed to enhance the loss of fat from visceral and skeletal depots. These strategies will be used in conjunction with a hypocaloric diet and will be compared to a hypocaloric diet alone to determine if either of these strategies are superior in reducing visceral fat and preserving muscle mass.

Interventions

  • DRUG Placebo
  • DRUG Pioglitazone
  • BEHAVIORAL Resistance exercise training to maximize muscle power
  • BEHAVIORAL Hypocaloric diet

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2006-04
Est. Completion 2007-04
Phase Phase 4

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT00315146

The ClinicalTrials.gov registry entry for NCT00315146 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT00315146 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00315146 about?

NCT00315146 is a clinical study titled "Optimizing Body Composition for Function in Older Adults". The purpose of this pilot study is to compare two strategies intended to improve the health of overweight older adults by improving body composition. One strategy, resistance training, is designed to preserve skeletal muscle mass. The other strategy, the use of a PPAR-γ agonist, is designed to enhan...

What is the current status of trial NCT00315146?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2006-04. Estimated completion is 2007-04.

What interventions are being tested in trial NCT00315146?

The interventions under investigation include: Placebo (DRUG), Pioglitazone (DRUG), Resistance exercise training to maximize muscle power (BEHAVIORAL), Hypocaloric diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT00315146?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.